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Abstract 
Plasmodium ovale is rare and not exactly known to be autochthonous in Malaysia. There are two distinct forms of the 
parasite, namely P. ovale curtisi (classic form) and P. ovale wallikeri (variant form). Here, the first sequence confirmed 
case of an imported P. ovale wallikeri infection in Malaysia is presented. Microscopy found Plasmodium parasites with 
morphology similar to P. ovale or Plasmodium vivax in the blood films. Further confirmation using polymerase chain 
reaction (PCR) targeting the small-subunit rRNA gene of the parasite was unsuccessful. Genus-specific PCR was then 
performed and the product was sequenced and analysed. Sequence analyses confirmed the aetiological agent as P. 
ovale wallikeri. New species-specific primers (rOVA1v and rOVA2v) were employed and P. ovale wallikeri was finally con-
firmed. The findings highlight the need to look out for imported malaria infections in Malaysia and the importance of 
a constantly updated and validated diagnostic technique.
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Background
Malaria is caused by the blood parasite Plasmodium. 
Plasmodium falciparum, Plasmodium vivax, Plas-
modium ovale curtisi, P. ovale wallikeri, Plasmodium 
knowlesi and Plasmodium malariae are known to infect 
humans. Current molecular-based diagnostic methods 
enable sensitive and specific detection of the five human 
malaria parasites, even in subclinical cases. Improved 
diagnostic techniques using polymerase chain reaction 
(PCR) detected a spike in prevalence of overall malaria 
infections. The relatively insensitive microscopic diag-
nosis has underestimated the prevalence of this disease, 
including P. ovale infection, which was once believed to 
be comparatively rare. Review of a series of studies led 
to a probable conclusion that a 2 to >10  % prevalence 
of P. ovale might actually exist in the general population 
of Africa and Papua New Guinea and among malaria 
patients in Southeast Asia [1].
Plasmodium ovale infection, a tertian malaria, is diffi-
cult to diagnose microscopically, owing to the generally 
low parasite density in patients and the parasite’s mor-
phology which resembles that of P. vivax. Additionally, 
it is a relapsing infection, which can occur long after 
the primary exposure to the parasite, initiated by latent 
parasites (hypnozoites) residing in the liver [2]. Moreo-
ver, dimorphism exists in the small-subunit rRNA (ssr-
RNA) gene of the parasite, causing some isolates to be 
undetectable by PCR but microscopically confirmed as P. 
ovale [3]. Further gene studies demonstrated two distinct, 
non-recombining sympatric species of the parasite [4]. 
Subsequently in 2010, Sutherland et al. [4] first coined P. 
ovale curtisi and P. ovale wallikeri as names for the classic 
and variant forms of P.ovale, respectively.
Hitherto, cases of P. ovale wallikeri infection have been 
described in certain countries in Southern Asia (e.g. 
Bangladesh and India) and almost throughout the whole 
of Southeast Asia [4–14]. In Malaysia currently, the most 
prevalent malaria parasite is P. knowlesi [15], with major-
ity of the cases originating from Malaysian Borneo. Seven 
known cases of P. ovale were reported so far in Malay-
sia [15–18]. Here, the first sequence confirmed case 
of an imported P. ovale wallikeri infection in a patient 
in Malaysia is reported. Microscopy, nested PCR and 
sequence analyses of the ssrRNA gene confirmed the 
aetiological agent as P. ovale wallikeri.
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Case presentation
A 19-year-old, Nigerian college student presented to 
Sunway Medical Centre, Selangor, Malaysia with a 4-day 
history of fever associated with chills, rigors and body 
ache. Prior to onset of symptoms, he had gone back to 
Nigeria for 10  days during semester break and became 
unwell 5 days after returning to Malaysia. He was febrile 
upon admission with body temperature of 39.8 °C, pulse 
rate of 126 beats per minute and blood pressure of 
128/87  mm  Hg. There were no other significant physi-
cal findings noted. He recalled to have had three epi-
sodes of malaria during childhood, but was uncertain 
about the causative Plasmodium species. Blood investi-
gation showed thrombocytopaenia with a platelet count 
of 71,000 per microlitre (normal: 150,000–400,000 per 
microlitre) and raised C-reactive protein (97 mg/L; nor-
mal: <5 mg/L). White blood cell count, haemoglobin and 
albumin levels were within the normal range. Dengue 
NS-1Ag, dengue IgM and IgG, Leptospira IgM, Myco-
plasma antibody test and Widal-Weil-Felix test were all 
negative. Blood cultures did not yield any result.
After three attempts using BinaxNOW® Malaria Test 
(USA), a T2 Line appeared, while no T1 Line (specific for 
P. falciparum infection) was observed, suggesting vivax, 
malariae or ovale malaria or a mix of these. Microscopy 
on thick and thin blood films detected the presence of 
malaria parasites suggesting P. ovale or P. vivax (Fig. 1), 
with 0.27 % parasitaemia.
DNA was extracted from whole blood collected in 
EDTA tube using the DNeasy® Blood and Tissue Kit 
(Qiagen, Germany). Four microlitres of the purified DNA 
was used in the primary PCR reaction, followed by a sec-
ondary PCR amplification using standard nested PCR 
method [16, 19] (Table  1). The PCR result was negative 
for all reactions except the reaction using genus-specific 
primers, rPLU3 and rPLU4. Gel electrophoresis showed 
a band of 240  bp, corresponding to the product of the 
genus-specific nest 2 PCR (Fig.  2). At the same time, 
NM-PCR, a nested multiplex malaria PCR and NG-PCR, 
a nested PCR for Plasmodium genus amplification were 
performed (Table  1), as previously described [20]. NG-
PCR also successfully amplified a positive product. The 
Fig. 1 Microphotographs of giemsa-stained thin blood films of the patient viewed under 1000 ×  magnification. a Developing schizont. b A 
schizont with eight merozoites. c, d Gametocyte. Infected red blood cell is enlarged, oval in shape with presence of Schuffner’s dots, clearly seen in b 
and d
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positive products of both PCRs were gel purified using 
QIAquick® Gel Extraction Kit (Qiagen, Germany) and 
cloned into pGEM®-T vector (Promega, USA). For each 
PCR product, ten clones were screened and three posi-
tive clones were randomly selected for plasmid sequenc-
ing. Plasmids were extracted using QIAprep® Spin 
Miniprep Kit (Qiagen, Germany) and sequenced using 
BigDye® Terminator v3.1 in ABI PRISM® 3730xl DNA 
Analyzer (Applied Biosystems). No definitive result 
was obtained from NM-PCR due to non-specific bands 
observed on the gel.
Sequencing data between clones were similar except 
for a few nucleotide differences. A consensus sequence 
was generated from the plasmid sequences of the 
clones for each PCR product and analysed using NCBI 
BLAST [21]. The result showed a 99  % identity to the 
ssrRNA gene of P. ovale wallikeri (GenBank accession 
number: AB182492.1, KF696360.1, KF018654.1). Sub-
sequently, the full nucleotide sequence (746 bp) of the 
product from NG-PCR (herein named UM00134; Gen-
Bank accession number: KU255080) was compared to 
those found in the GenBank in a phylogenetic analysis 
using the MEGA 6.06 program [22]. Sequences were 
trimmed and aligned using Clustal W [23]. A phyloge-
netic tree was constructed using the neighbour-join-
ing methods [24] and Jukes-Cantor model [25], with 
a Bootstrap value of 1000 (Fig.  3). Sequence analyses 
confirmed that the infecting Plasmodium species was P. 
ovale wallikeri.
In light of this finding, primers rOVA1v and rOVA2v 
which are specific for P. ovale wallikeri [3], were used 
in the Nest 2 PCR reaction under the same condition 
as mentioned in Table  1. Primers rOVA1 and rOVA2 
were included to exclude P. ovale curtisi infection. Par-
allel to that, a mixture of primer sets rOVA1/rOVA2 
and rOVA1v/rOVA2v, besides primer set rOVA1WC/
rOVA2WC [26] which are able to detect both P. ovale 
forms were also employed. Positive products were 
Table 1 Description of PCR protocols used in this report
a Cycling condition: Initial denaturation, 94 °C for 4 min; 35 cycles of 94 °C for 1 min, 55 °C for 1 min and 72 °C for 1 min; final extension 72 °C for 10 min. Four µL of 
DNA is used in a 25 µL reaction volume containing 4 mM magnesium chloride, 0.2 mM of each dNTPs and 1 Unit of Taq polymerase
b Cycling condition: Initial denaturation, 94 °C for 4 min; 35 cycles of 94 °C for 1 min, 58 °C for 1 min and 72 °C for 1 min; final extension 72 °C for 10 min. Four µL of 
nest one product is used in a 25 µL reaction volume containing 4 mM magnesium chloride, 0.2 mM of each dNTPs and 1 Unit of Taq polymerase
c Cycling condition is the same as Nest 2 PCRb. Primer sets rOVA1/rOVA2 and rOVA1v/rOVA2v are mixed in equimolar in a single PCR reaction tube. Four µL of nest one 
product is used in a 25 µL reaction volume containing 4 mM magnesium chloride, 0.2 mM of each dNTPs and 1 Unit of Taq polymerase
d Cycling condition: Initial denaturation, 94 °C for 5 min; 35 cycles of 94 °C for 1 min, 58 °C for 1 min and 72 °C for 1 min; final extension 72 °C for 10 min. Five µL of 
DNA is used in a 50 µL reaction volume containing 4 mM magnesium chloride, 0.2 mM of each dNTPs and 2 Units of Taq polymerase
e Cycling condition: Initial denaturation, 94 °C for 5 min; 35 cycles of 94 °C for 1 min, 53 °C for 1 min and 72 °C for 1 min; final extension 72 °C for 10 min. Two µL of 
Primary PCR product is used in a 25 µL reaction volume containing 4 mM magnesium chloride, 0.2 mM of each dNTPs and 1 Unit of Taq polymerase
f Cycling condition is the same as NM-PCRe. Two µL of Primary PCR product is used in a 50 µL reaction volume containing 4 mM magnesium chloride, 0.2 mM of each 
dNTPs and 2 Units of Taq polymerase
Reaction Primer Annealing  
temperature (°C)
Product size (bp) Target species Reference
Nested PCR
Nest 1a rPLU1/rPLU5 55 ≈1670 Plasmodium spp. [19]
Nest 2b rPLU3/rPLU4 240 Plasmodium spp.
rFal1/rFal2 205 P. falciparum
rVIV1/rVIV2 120 P. vivax
rMAL1/rMAL2 145 P. malariae
rOVA1/rOVA2 58 787–789 P. ovale curtisi
Pmk8/Pmkr9 153 P. knowlesi [16]
rOVA1v/rOVA2v 782 P. ovale wallikeri [3]
rOVA1WC/rOVA2WC 659–662 P. ovale curtisi and P. ovale wallikeri [26]
Mixed P. ovalec rOVA1/rOVA2 and rOVA1v/rOVA2v 58 782–789 P. ovale curtisi and P. ovale wallikeri [3]
NM- and NG-PCR
Primary PCRd UNR/PLF 58 783–821 Universal [20]
NM
PCRe
New PLFshort with 53 Plasmodium spp.
MARshort 241 P. malariae
FARshort 370 P. falciparum
OVRshort 407 P. ovale
VIRshort 476 P. vivax
NG-PCRf NewPLFshort/NewRevshort 53 735–773 Plasmodium spp.
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obtained from the PCR. The mixture of these primer 
sets in a single Nest 2 PCR reaction and primer set 
rOVA1WC/rOVA2WC were able to detect P. ovale wal-
likeri (Fig. 4).
The patient was immediately treated with a course of 
Riamet® (artemether/lumefantrine) following detec-
tion of malaria parasites. His symptoms improved 
within 24  h of treatment but blood film for malaria 
became negative only after 36  h of treatment. How-
ever his platelet count seems to be slow to recover 
while C-reactive protein, which is known as a marker 
for severity in malaria [27], improved steadily fol-
lowing treatment. Primaquine 30  mg base daily was 
added 2 days after Riamet. He requested for discharge 
and agreed to complete the two-week course of pri-
maquine at home. He continued to improve clinically 
post-discharge but could not afford to repeat his blood 
tests and dropped out from subsequent out-patient 
follow up visit.
Consent
The study was approved by the University of Malaya 
Medical Centre Medical Ethics Committee (MEC Ref. 
No: 817.18).
Discussion
In Malaysia, two of the seven ovale malaria were reported 
to be caused by P. ovale curtisi [18]. No known ovale 
infection in the country was sequence-confirmed to 
be caused by P. ovale wallikeri, up till now. Diagno-
sis of ovale malaria is a challenge, due to the parasite’s 
low density and close morphological resemblance to P. 
vivax. Both the classic and variant forms of P. ovale are 
also morphologically indistinguishable from each other 
[26]. Rapid diagnostic tests (RDT) have aided in the 
rapid diagnosis of malaria and other infectious diseases. 
Nonetheless, their apparent ineffectiveness in detecting 
P. ovale turns out to be well documented [28, 29]. In this 
case, the result of the RDT, BinaxNOW® Malaria Test 
was negative twice before a faint line indicating Plasmo-
dium species infection appeared on the third attempt.
Nested PCR for molecular detection of Plasmodium 
spp. [30] has emerged as a standard molecular method 
for malaria diagnosis. However, the primers for P. ovale 
detection (rOVA1/rOVA2) were unable to identify the 
variant form of the parasite, until a new set of primers 
(rOVA1v/rOVA2v) specific for P. ovale wallikeri and a 
set of primers (rOVA1WC/rOVA2WC) to detect both 
forms were introduced [3, 26]. The initial negative PCR 
Fig. 2 2 % agarose gel electrophoresis of Nest 2 PCR showing an amplified product with the genus-specific primers. 1 100 bp DNA ladder; 2 rFAL1/
rFAL2 (P. falciparum); 3 rOVA1/rOVA2 (P. ovale); 4 rMAL1/rMAL2 (P. malariae); 5 rVIV1/rVIV2 (P. vivax); 6 Pmk8/Pmkr9 (P. knowlesi); 7 rPLU3/rPLU4 (Plasmo-
dium spp.); 8–13 no template control of P. falciparum, P. ovale, P. malariae, P. vivax, P. knowlesi, and Plasmodium spp., respectively
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result using the species-specific primers and subsequent 
sequencing analyses were indicative of P. ovale wal-
likeri infection, prompting the use of these new prim-
ers. Besides, primer sets rOVA1/rOVA2 and rOVA1v/
rOVA2v were mixed to detect both P. ovale wallikeri 
and P. ovale curtisi in a single Nest 2 duplex PCR reac-
tion. The mixed primers and primer set rOVA1WC/
rOVA2WC in the PCR reaction appeared to be a mean 
for quick and cost-efficient detection of both species of P. 
ovale [26], and therefore should replace primers rOVA1/
rOVA2 for routine diagnosis of malaria.
The accurate diagnosis of P. ovale infection, in fact of 
all malaria infection, is crucial to avoid the delay of treat-
ment and clinical complications. Though ovale malaria is 
thought to be rather benign, associated severe complica-
tions such as acute respiratory distress syndrome (ARDS) 
[31, 32], splenic complication [33], acute renal failure and 
ultimately, death [18, 34] have been reported. There are 
certain clinical features slightly distinctive of the two dif-
ferent forms of P. ovale. The latency periods of P. ovale 
curtisi and P. ovale wallikeri infection are reported to be 
66.1–111.1 days and 28.9–57 days, respectively, with one 
case of P. ovale curtisi infection displaying an extraor-
dinarily long latency period of 1083  days [35]. This 
shorter latency period may lead to higher relapse rate 
of P. ovale wallikeri infection. A trend toward a shorter 
stay in Africa and shorter period of time between onset 
of symptoms and diagnosis was found among patients 
with P. ovale wallikeri infection, possibly reflecting easier 
transmission, shorter latency or higher relapse rates [6]. 
In addition, patients with P. ovale wallikeri infection have 
significantly more severe thrombocytopaenia and rela-
tively higher parasitaemia than those with P. ovale curtisi 
infection. Other non-significant, differentiating features 
include shorter pre-patent period, lower albumin level, 
higher body temperature and more markers of haemoly-
sis in P. ovale wallikeri infection compared to that of P. 
ovale curtisi [6]. Taken together, it may seem that man-
agement of P. ovale wallikeri could be slightly more com-
plicated than P. ovale curtisi.
Plasmodium ovale is not exactly known to be autoch-
thonous in Malaysia. It is absolutely undesirable for 
P. ovale to be transmitting within the country, espe-
cially when Malaysia is progressing towards elimination 
of malaria by 2020. Relapsing ovale infection is often 
asymptomatic, detected only by continued examination 
of blood films [2]. In other words, human reservoir of 
P. ovale may stay under the radar. This poses a threat to 
the public health because natural transmission of ovale 
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Fig. 3 Phylogenetic analysis of the NG-PCR product (UM00134). The phylogenetic tree is constructed using the Neighbor-Joining methods and 
Jukes–Cantor model, with Bootstrap value of 1000. The patient isolate, UM00134 is clustered with P. ovale wallikeri isolates. GenBank accession 
number is given after each isolate’s name
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of two vectors, Anopheles maculatus [36] and Anopheles 
dirus [37] which have been shown to be good experi-
mental vectors for P. ovale. Nolder et al. [35] also found 
that, compared to other human malaria, ovale malaria 
is less likely to be prevented by chemoprophylaxis. Fur-
thermore, as pointed out by Mellon et al. [38], with non-
specific clinical signs as well as long latency period of P. 
ovale infection [2, 6, 35], what then should the maximum 
exclusion period be for blood donors who had travelled 
to endemic areas? Transfusion-transmitted P. ovale infec-
tion had been reported and can be severe [39].
It was not discernable if the patient was experiencing a 
relapse or acute malaria. Prepatent period (time between 
sporozoite inoculation and the first detection of parasites 
in blood) for ovale malaria is reported to be 12–20 days 
[2]. Lastly, a similar case was reported by Li et  al. [29], 
whereby P. ovale wallikeri infection was diagnosed in a 
Chinese worker returning from West Africa. This and 
other increasing worldwide reports of P. ovale infections 
[40–43] and misdiagnosed cases [7] urge the health and 
research sectors to devise and utilise accurate techniques 
to diagnose this infectious disease.
Conclusions
The current findings highlight the need for continu-
ously updating and validating diagnostic techniques for 
malaria. Complete history taking is of utmost impor-
tance in patients as it aids diagnosis, especially in the 
case of P. ovale infection where it can remain latent and 
asymptomatic for a long period of time. Imported cases 
of malaria are a concern for public health, especially in 
countries where malaria is non-existent or has been elim-
inated. With Malaysia’s open policy and the ease of travel, 
healthcare personnel should be made aware of the pos-
sible imported infections entering the country.
Authors’ contributions
JWKL performed the molecular biology techniques and drafted the manu-
script. RM performed the microscopy. LHT presented the patient’s history and 
clinical symptoms. YLL conceptualize the manuscript. All authors read and 
approved the final manuscript.
Author details
1 Department of Parasitology, Faculty of Medicine, University of Malaya, 
50603 Kuala Lumpur, Malaysia. 2 Sunway Medical Centre, Bandar Sunway, 
46150 Petaling Jaya, Selangor, Malaysia. 
Acknowledgements
This work was supported by University of Malaya High Impact Research Grant 
(UM.C/625/1/HIR/MOHE/CHAN/14/3) from the Ministry of Higher Educa-
tion, Malaysia. The authors would like to thank the Parasites: South East Asian 
Diagnostic (PARA:SEAD) Laboratory, Kuala Lumpur, Malaysia for the assistance 
during diagnosis.
Competing interests
The authors declare that they have no competing interests.
Received: 15 October 2015   Accepted: 23 December 2015
References
 1. Mueller I, Zimmerman PA, Reeder JC. Plasmodium malariae and Plasmo-
dium ovale–the “bashful” malaria parasites. Trends Parasitol. 2007;23:278–
83. doi:10.1016/j.pt.2007.04.009.
 2. Collins WE, Jeffery GM. Plasmodium ovale: parasite and disease. Clin 
Microbiol Rev. 2005;18:570–81. doi:10.1128/cmr.18.3.570-581.2005.
 3. Calderaro A, Piccolo G, Perandin F, Gorrini C, Peruzzi S, Zuelli C, et al. 
Genetic polymorphisms influence Plasmodium ovale PCR detection 
accuracy. J Clin Microbiol. 2007;45:1624–7. doi:10.1128/jcm.02316-06.
 4. Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrit-
tayakamee S, et al. Two nonrecombining sympatric forms of the 
human malaria parasite Plasmodium ovale occur globally. J Infect Dis. 
2010;201:1544–50. doi:10.1086/652240.
 5. Fuehrer HP, Habler VE, Fally MA, Harl J, Starzengruber P, Swoboda P, et al. 
Plasmodium ovale in Bangladesh: genetic diversity and the first known 
evidence of the sympatric distribution of Plasmodium ovale curtisi and 
Plasmodium ovale wallikeri in southern Asia. Int J Parasitol. 2012;42:693–9. 
doi:10.1016/j.ijpara.2012.04.015.
 6. Rojo-Marcos G, Rubio-Muñoz Jé M, Ramírez-Olivencia G, García-Bujalance 
S, Elcuaz-Romano R, Díaz-Menéndez M, et al. Comparison of imported 
Plasmodium ovale curtisi and P. ovale wallikeri infections among patients 
in Spain, 2005–2011. Emerg Infect Dis. 2014;20:409–16. doi:10.3201/
eid2003.130745.
 7. Chavatte J-M, Tan S, Snounou G, Lin R. Molecular characterization of 
misidentified Plasmodium ovale imported cases in Singapore. Malar J. 
2015;14:454.
Fig. 4 Detection of P. ovale wallikeri using primer sets rOVA1/
rOVA2, rOVA1v/rOVA2v, mixture of both primer sets and rOVA1WC/
rOVA2WC. A 2 % agarose gel electrophoresis was performed. Parasite 
DNA purified from patient blood is used as template of PCR. 1 100 bp 
DNA ladder; 2 rOVA1/rOVA2 (P. ovale curtisi); 3 rOVA1v/rOVA2v (P. ovale 
wallikeri); 4 Mixture of primer sets rOVA1/rOVA2 and rOVA1v/rOVA2v 
(both forms of P. ovale); 5 rOVA1WC/rOVA2WC (both forms of P. ovale)
Page 7 of 7Liew et al. Malar J  (2016) 15:8 
 8. Incardona S, Chy S, Chiv L, Nhem S, Sem R, Hewitt S, et al. Large sequence 
heterogeneity of the small subunit ribosomal RNA gene of Plasmodium 
ovale in Cambodia. Am J Trop Med Hyg. 2005;72:719–24.
 9. Toma H, Kobayashi J, Vannachone B, Arakawa T, Sato Y, Nambanya S, et al. 
Plasmodium ovale infections detected by PCR assay in Lao PDR. Southeast 
Asian J Trop Med Public Health. 1999;30:620–2.
 10. Wickremasinghe R, Galapaththy GN, Fernando WA, de Monbrison F, 
Wijesinghe RS, Mendis KN, et al. An indigenous case of Plasmodium ovale 
infection in Sri Lanka. Am J Trop Med Hyg. 2008;78:206–7.
 11. Win TT, Lin K, Mizuno S, Zhou M, Liu Q, Ferreira MU, et al. Wide distribu-
tion of Plasmodium ovale in Myanmar. Trop Med Int Health. 2002;7:231–9.
 12. Zhou M, Liu Q, Wongsrichanalai C, Suwonkerd W, Panart K, Prajakwong 
S, et al. High prevalence of Plasmodium malariae and Plasmodium ovale 
in malaria patients along the Thai-Myanmar border, as revealed by 
acridine orange staining and PCR-based diagnoses. Trop Med Int Health. 
1998;3:304–12.
 13. Baird JK. Purnomo, Masbar S. Plasmodium ovale in Indonesia. Southeast 
Asian J Trop Med Public Health. 1990;21:541–4.
 14. Cabrera BD, Arambulo PV 3rd. Malaria in the Republic of the Philippines: a 
review. Acta Trop. 1977;34:265–79.
 15. Yusof R, Lau YL, Mahmud R, Fong MY, Jelip J, Ngian HU, et al. High pro-
portion of knowlesi malaria in recent malaria cases in Malaysia. Malar J. 
2014;13:168.
 16. Singh B, Lee KS, Matusop A, Radhakrishnan A, Shamsul SSG, Cox-Singh J, 
et al. A large focus of naturally acquired Plasmodium knowlesi infections in 
human beings. Lancet. 2004;363:1017–24.
 17. Lim YAL, Mahmud R, Chew CH, T T, Chua KH. Plasmodium ovale 
infection in Malaysia: first imported case. Malar J. 2010;9:272. 
doi:10.1186/1475-2875-9-272.
 18. Lau YL, Lee WC, Tan LH, Kamarulzaman A, Syed Omar SF, Fong MY, 
et al. Acute respiratory distress syndrome and acute renal failure from 
Plasmodium ovale infection with fatal outcome. Malar J. 2013;12:389. 
doi:10.1186/1475-2875-12-389.
 19. Singh B, Bobogare A, Cox-Singh J, Snounou G, Abdullah MS, Rahman 
HA. A genus- and species-specific nested polymerase chain reaction 
malaria detection assay for epidemiologic studies. Am J Trop Med Hyg. 
1999;60:687–92.
 20. Ta TH, Hisam S, Lanza M, Jiram AI, Ismail N, Rubio JM. First case of a 
naturally acquired human infection with Plasmodium cynomolgi. Malar J. 
2014;13:68. doi:10.1186/1475-2875-13-68.
 21. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local 
alignment search tool. J Mol Biol. 1990;215:403–10. doi:10.1016/
s0022-2836(05)80360-2.
 22. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular 
evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. 
doi:10.1093/molbev/mst197.
 23. Thompson JD, Higgins DG, Gibson TJ, Clustal W. Improving the sensitivity 
of progressive multiple sequence alignment through sequence weight-
ing, position-specific gap penalties and weight matrix choice. Nucleic 
Acids Res. 1994;22:4673–80.
 24. Saitou N, Nei M. The neighbor-joining method: a new method for recon-
structing phylogenetic trees. Mol Biol Evol. 1987;4:406–25.
 25. Jukes TH, Cantor CR. Evolution of protein molecules. In: Munro HN, editor. 
Mammalian protein metabolism III. New York: Academic Press; 1969. p. 
21–132.
 26. Fuehrer HP, Stadler MT, Buczolich K, Bloeschl I, Noedl H. Two tech-
niques for simultaneous identification of Plasmodium ovale curtisi and 
Plasmodium ovale wallikeri by use of the small-subunit rRNA gene. J Clin 
Microbiol. 2012;50:4100–2. doi:10.1128/jcm.02180-12.
 27. Paul R, Sinha PK, Bhattacharya R, Banerjee AK, Raychaudhuri P, Mondal J. 
Study of C reactive protein as a prognostic marker in malaria from Eastern 
India. Adv Biomed Res. 2012;1:41. doi:10.4103/2277-9175.100140.
 28. Bauffe F, Desplans J, Fraisier C, Parzy D. Real-time PCR assay for dis-
crimination of Plasmodium ovale curtisi and Plasmodium ovale wallikeri 
in the Ivory Coast and in the Comoros Islands. Malar J. 2012;11:307. 
doi:10.1186/1475-2875-11-307.
 29. Li Y, Wang G, Sun D, Meng F, Lin S, Hu X, et al. A case of Plasmodium ovale 
wallikeri infection in a Chinese worker returning from West Africa. Korean 
J Parasitol. 2013;51:557–62. doi:10.3347/kjp.2013.51.5.557.
 30. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, 
et al. High sensitivity of detection of human malaria parasites by the 
use of nested polymerase chain reaction. Mol Biochem Parasitol. 
1993;61:315–20.
 31. Lee EY, Maguire JH. Acute pulmonary edema complicating ovale malaria. 
Clin Infect Dis. 1999;29:697–8.
 32. Rojo-Marcos G, Cuadros-Gonzalez J, Mesa-Latorre JM, Culebras-Lopez 
AM, de Pablo-Sanchez R. Acute respiratory distress syndrome in a case of 
Plasmodium ovale malaria. Am J Trop Med Hyg. 2008;79:391–3.
 33. Cinquetti G, Banal F, Rondel C, Plancade D, de Saint Roman 
C, Adriamanantena D, et al. Splenic infarction during Plasmo-
dium ovale acute malaria: first case reported. Malar J. 2010;9:288. 
doi:10.1186/1475-2875-9-288.
 34. Hachimi MA, Hatim EA, Moudden MK, Elkartouti A, Errami M, Louzi L, 
et al. The acute respiratory distress syndrome in malaria: is it always the 
prerogative of Plasmodium falciparum? Rev Pneumol Clin. 2013;69:283–6. 
doi:10.1016/j.pneumo.2013.03.001.
 35. Nolder D, Oguike MC, Maxwell-Scott H, Niyazi HA, Smith V, Chiodini PL, 
et al. An observational study of malaria in British travellers: Plasmodium 
ovale wallikeri and Plasmodium ovale curtisi differ significantly in the dura-
tion of latency. BMJ Open. 2013;3:5. doi:10.1136/bmjopen-2013-002711.
 36. Chin W, Contacos PG, Buxbaum JN. The transmission of a West African 
strain of Plasmodium ovale by Anopheles freeborni and Anopheles macula-
tus. Am J Trop Med Hyg. 1966;15:690–3.
 37. Coatney GR, Collins WE, Warren M, Contacos PG. The primate malarias. 
Atlanta: CDC; 1971.
 38. Mellon G, Ficko C, Thellier M, Kendjo E, Aoun O, Adriamanantena D, et al. 
Two cases of late Plasmodium ovale presentation in military personnel. J 
Travel Med. 2014;21:52–4. doi:10.1111/jtm.12077.
 39. Haydoura S, Mazboudi O, Charafeddine K, Bouakl I, Baban TA, Taher AT, 
et al. Transfusion-related Plasmodium ovale malaria complicated by acute 
respiratory distress syndrome (ARDS) in a non-endemic country. Parasitol 
Int. 2011;60:114–6. doi:10.1016/j.parint.2010.10.005.
 40. de Laval F, Simon F, Bogreau H, Rapp C, Wurtz N, Oliver M, et al. Emer-
gence of Plasmodium ovale malaria among the French armed forces in 
the Republic of Ivory Coast: 20 years of clinical and biological experience. 
Clin Infect Dis. 2014;58:e122–8. doi:10.1093/cid/ciu021.
 41. Li M, Xia Z, Yan H. New type of SSUrDNA sequence was detected from 
both Plasmodium ovale curtisi and Plasmodium ovale wallikeri samples. 
Malar J. 2014;13:216.
 42. Castellanos Mí E, Díaz S, Parsons E, Peruski LF, Enríquez F, Ramírez JL, et al. 
First imported Plasmodium ovale malaria in Central America: case report 
of a Guatemalan soldier and a call to improve its accurate diagnosis. Mil 
Med Res. 2015;2:3. doi:10.1186/s40779-015-0030-9.
 43. Chaturvedi N, Bhandari S, Bharti PK, Basak SK, Singh MP, Singh N. Sympa-
tric distribution of Plasmodium ovale curtisi and P. ovale wallikeri in India: 
implication for the diagnosis of malaria and its control. Trans R Soc Trop 
Med Hyg. 2015;109:352–4. doi:10.1093/trstmh/trv015.
